SpaceX Postpones Starship Launch Amid Anticipated Mega Share Sale Kevin Warsh Set to Be Sworn In as Federal Reserve Chair on Friday Wall Street Futures Edge Higher on AI Optimism and Middle East Truce Hopes EU and Mexico Sign Updated Trade Deal to Reduce Dependence on US and China Fraudulent Art Scheme Targeting Sothebys Underscores Auction House Due Diligence Risks India and Cyprus Elevate Bilateral Ties to Strategic Partnership with Six New Agreements ArtsWay Manufacturing Q4 2024 Earnings Modest Profitability Sustained Amid Quiet Quarter Adient Q1 2026 Earnings Earnings Beat Drives Stock Higher Amid Mixed Operational Signals Guardian Pharmacy Services GRDN Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Movement UP Q1 2026 Earnings Steep Loss Reported as Stock Surges on Strategic Progress PONY Q1 2026 Earnings Narrower Loss Per ADS Drives Positive Investor Sentiment APPS Q1 2026 Earnings EPS Surges 845 Above Estimates Shares Rally 57 NXP Semiconductors NXPI Surges Over 4 as Sector Momentum Builds Key Levels to Watch Lithia Motors LAD Gains Nearly 2 as Shares Test Key Resistance Zone SharonAI Holdings Inc SHAZ Surges 139 Breakout Momentum Builds Above Key Support Elutia Inc ELUT Holds Near Key Support After Marginal Decline Compass Inc COMP Declines as Real Estate Headwinds Persist Key Support Levels in Focus Pakistan Army Chief Joins QatarLed Mediation in USIran Tensions Regional Stability in Focus AVX Q1 2026 Earnings Loss Per Share and Stock Decline Highlight Challenges 1st Source Corporation SRCE Holds Steady Near Support as Trading Volume Remains Moderate Target Hospitality Corp TH Q1 2026 Earnings EPS Misses Estimates Amidst Operational Challenges APEI Q1 2026 Earnings EPS Surges Past Estimates by 38 Yet Stock Slips VNDA Q1 2026 Earnings WiderThanExpected Loss Raises Concerns Biogen Q1 2026 Earnings EPS Surges Past Estimates Stock Rises CAPS Q1 2026 Earnings EPS Misses Estimates as Losses Widen on Operational Challenges Armata Pharmaceuticals ARMP Q1 2026 Earnings Steep EPS Miss as ClinicalStage Biotech Continues Heavy RD Spending ZVRA Q1 2026 Earnings Surprise EPS Profit Despite No Reported Revenue